Sigachi Industries Limited (SIGACHI.NS)
INR 52.6
(2.59%)
INR 52.6
(2.59%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.47 Billion INR | 26.35% |
| 2022 | 521.19 Million INR | 3.95% |
| 2021 | 501.39 Million INR | 26.85% |
| 2020 | 395.27 Million INR | 49.46% |
| 2019 | 264.47 Million INR | -4.36% |
| 2018 | 276.52 Million INR | 122.44% |
| 2017 | 124.31 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 178.77 Million INR | 39.25% |
| 2023 FY | 658.51 Million INR | 26.35% |
| 2023 Q4 | 128.37 Million INR | -40.22% |
| 2023 Q1 | 143.51 Million INR | 22.17% |
| 2023 Q2 | 200 Million INR | 39.36% |
| 2023 Q3 | 214.76 Million INR | 7.38% |
| 2022 Q1 | 154.58 Million INR | 11.58% |
| 2022 Q4 | 117.47 Million INR | -13.14% |
| 2022 Q3 | 135.24 Million INR | -17.62% |
| 2022 Q2 | 164.16 Million INR | 6.19% |
| 2022 FY | 521.19 Million INR | 3.95% |
| 2021 Q3 | 119.17 Million INR | -6.54% |
| 2021 Q4 | 138.54 Million INR | 16.25% |
| 2021 Q2 | 127.51 Million INR | 9.76% |
| 2021 Q1 | 116.17 Million INR | -16.2% |
| 2021 FY | 501.39 Million INR | 26.85% |
| 2020 FY | 395.27 Million INR | 49.46% |
| 2020 Q3 | 81.72 Million INR | -10.26% |
| 2020 Q2 | 91.06 Million INR | -2.0% |
| 2020 Q1 | 92.92 Million INR | 0.0% |
| 2020 Q4 | 138.63 Million INR | 69.64% |
| 2019 FY | 264.47 Million INR | -4.36% |
| 2018 FY | 276.52 Million INR | 122.44% |
| 2017 FY | 124.31 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Ind-Swift Limited | 1.22 Billion INR | -20.223% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Sakar Healthcare Limited | 495.5 Million INR | -197.453% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 98.59% |
| Innova Captab Limited | 2.53 Billion INR | 41.822% |
| Divi's Laboratories Limited | 18.31 Billion INR | 91.95% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | 67.056% |
| Morepen Laboratories Limited | 4.17 Billion INR | 64.687% |
| Mankind Pharma Limited | 40.86 Billion INR | 96.393% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Wanbury Limited | 1.7 Billion INR | 13.666% |
| Laurus Labs Limited | 3.94 Billion INR | 62.673% |
| Nectar Lifesciences Limited | 3.89 Billion INR | 62.116% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 83.585% |
| Alembic Limited | 767.77 Million INR | -91.971% |
| Hikal Limited | 1.49 Billion INR | 1.359% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 74.403% |
| Neuland Laboratories Limited | 5.31 Billion INR | 72.285% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 80.457% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 77.333% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 70.177% |
| Themis Medicare Limited | 1.3 Billion INR | -13.106% |
| RPG Life Sciences Limited | 2.29 Billion INR | 35.702% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 96.753% |
| Lupin Limited | 27.75 Billion INR | 94.69% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -137.332% |
| Wockhardt Limited | 140 Million INR | -952.783% |
| Vaishali Pharma Limited | 6.29 Million INR | -23317.477% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 52.882% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -588.608% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 71.596% |
| FDC Limited | 3.03 Billion INR | 51.417% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 97.824% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -608.434% |
| Eris Lifesciences Limited | 5.18 Billion INR | 71.556% |
| Venus Remedies Limited | 534.65 Million INR | -175.674% |
| ZIM Laboratories Limited | 1.09 Billion INR | -34.221% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -19.732% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -167.209% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 79.601% |
| Shilpa Medicare Limited | 3.76 Billion INR | 60.817% |
| Albert David Limited | 1.33 Billion INR | -10.449% |
| Ajanta Pharma Limited | 19.67 Billion INR | 92.51% |
| Hester Biosciences Limited | 364.77 Million INR | -304.062% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 68.012% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 138.254% |
| Gufic Biosciences Limited | 2.89 Billion INR | 49.067% |
| Windlas Biotech Limited | 1.29 Billion INR | -13.474% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 47.096% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -51965.934% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -5267.82% |
| Granules India Limited | 6.52 Billion INR | 77.423% |
| Aarti Drugs Limited | 7.14 Billion INR | 79.382% |
| Bal Pharma Limited | 214.56 Million INR | -586.91% |
| Alkem Laboratories Limited | 19.46 Billion INR | 92.427% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 98.587% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | 22.684% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -520.167% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -7035.438% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Orchid Pharma Limited | 2.36 Billion INR | 37.575% |
| Medico Remedies Limited | 277.11 Million INR | -431.866% |
| Ind-Swift Laboratories Limited | 2 Billion INR | 26.637% |
| Ipca Laboratories Limited | 29.59 Billion INR | 95.02% |
| Brooks Laboratories Limited | -72.25 Million INR | 2139.938% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -491.33% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 94.182% |
| NATCO Pharma Limited | 25.96 Billion INR | 94.323% |
| Suven Life Sciences Limited | -1.22 Billion INR | 220.237% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 71.796% |
| Indoco Remedies Limited | 1.52 Billion INR | 3.313% |
| Alpa Laboratories Limited | 61.51 Million INR | -2295.994% |
| Lasa Supergenerics Limited | -458 Million INR | 421.808% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 135.817% |